Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine

F. Facchinetti, E. Martignoni, L. Fioroni, G. Sances, A. R. Genazzani

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

To assess the biological correlates of the precipitation of migraine attacks in the perimenstrual period, plasma β-endorphin (β-EP) and cortisol responses to naloxone (8 mg iv) and corticotropin releasing hormone (100 μg iv) were evaluated in both the follicular phase and the premenstrual period in 7 patients suffering from menstrual migraine and in 7 healthy, asymptomatic control volunteers. In the controls, naloxone evoked a significant release of both β-EP (F = 5.86, p <0.002) and cortisol (F = 4.43, p <0.008), independently of the menstrual cycle phase (F = 0.31 and 1.04, for β-EP and cortisol, respectively). Menstrual migraine patients, on the other hand, showed a significant hormone response only in the follicular phase, not in the premenstrual period. Corticotropin releasing hormone significantly increased β-EP and cortisol in both the controls and the menstrual migraine patients, independently of the menstrual cycle phase. In both the naloxone and corticotropin releasing hormone testings, the basal β-EP levels measured in the premenstrual period were lower than those observed in the follicular phase (p <0.02). These data demonstrate a cyclical, premenstrual dysfunction of the hypothalamic control exerted by opioids on the hypothalamus-pituitary-adrenal axis. Impairment of this fundamental adaptive mechanism (involved in stress responses and in pain control) could establish a causal relationship between menstrual-related migraine attacks and premenstrual opioid hyposensitivity.

Original languageEnglish
Pages (from-to)51-56
Number of pages6
JournalCephalalgia
Volume10
Issue number1
DOIs
Publication statusPublished - 1990

Fingerprint

Migraine Disorders
Opioid Analgesics
Hypothalamus
Follicular Phase
Hydrocortisone
Corticotropin-Releasing Hormone
Naloxone
Menstrual Cycle
Endorphins
Volunteers
Hormones
Pain

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine. / Facchinetti, F.; Martignoni, E.; Fioroni, L.; Sances, G.; Genazzani, A. R.

In: Cephalalgia, Vol. 10, No. 1, 1990, p. 51-56.

Research output: Contribution to journalArticle

Facchinetti, F. ; Martignoni, E. ; Fioroni, L. ; Sances, G. ; Genazzani, A. R. / Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine. In: Cephalalgia. 1990 ; Vol. 10, No. 1. pp. 51-56.
@article{82aea4d0ac3643e6870ec5cf7c718049,
title = "Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine",
abstract = "To assess the biological correlates of the precipitation of migraine attacks in the perimenstrual period, plasma β-endorphin (β-EP) and cortisol responses to naloxone (8 mg iv) and corticotropin releasing hormone (100 μg iv) were evaluated in both the follicular phase and the premenstrual period in 7 patients suffering from menstrual migraine and in 7 healthy, asymptomatic control volunteers. In the controls, naloxone evoked a significant release of both β-EP (F = 5.86, p <0.002) and cortisol (F = 4.43, p <0.008), independently of the menstrual cycle phase (F = 0.31 and 1.04, for β-EP and cortisol, respectively). Menstrual migraine patients, on the other hand, showed a significant hormone response only in the follicular phase, not in the premenstrual period. Corticotropin releasing hormone significantly increased β-EP and cortisol in both the controls and the menstrual migraine patients, independently of the menstrual cycle phase. In both the naloxone and corticotropin releasing hormone testings, the basal β-EP levels measured in the premenstrual period were lower than those observed in the follicular phase (p <0.02). These data demonstrate a cyclical, premenstrual dysfunction of the hypothalamic control exerted by opioids on the hypothalamus-pituitary-adrenal axis. Impairment of this fundamental adaptive mechanism (involved in stress responses and in pain control) could establish a causal relationship between menstrual-related migraine attacks and premenstrual opioid hyposensitivity.",
author = "F. Facchinetti and E. Martignoni and L. Fioroni and G. Sances and Genazzani, {A. R.}",
year = "1990",
doi = "10.1046/j.1468-2982.1990.1001051.x",
language = "English",
volume = "10",
pages = "51--56",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine

AU - Facchinetti, F.

AU - Martignoni, E.

AU - Fioroni, L.

AU - Sances, G.

AU - Genazzani, A. R.

PY - 1990

Y1 - 1990

N2 - To assess the biological correlates of the precipitation of migraine attacks in the perimenstrual period, plasma β-endorphin (β-EP) and cortisol responses to naloxone (8 mg iv) and corticotropin releasing hormone (100 μg iv) were evaluated in both the follicular phase and the premenstrual period in 7 patients suffering from menstrual migraine and in 7 healthy, asymptomatic control volunteers. In the controls, naloxone evoked a significant release of both β-EP (F = 5.86, p <0.002) and cortisol (F = 4.43, p <0.008), independently of the menstrual cycle phase (F = 0.31 and 1.04, for β-EP and cortisol, respectively). Menstrual migraine patients, on the other hand, showed a significant hormone response only in the follicular phase, not in the premenstrual period. Corticotropin releasing hormone significantly increased β-EP and cortisol in both the controls and the menstrual migraine patients, independently of the menstrual cycle phase. In both the naloxone and corticotropin releasing hormone testings, the basal β-EP levels measured in the premenstrual period were lower than those observed in the follicular phase (p <0.02). These data demonstrate a cyclical, premenstrual dysfunction of the hypothalamic control exerted by opioids on the hypothalamus-pituitary-adrenal axis. Impairment of this fundamental adaptive mechanism (involved in stress responses and in pain control) could establish a causal relationship between menstrual-related migraine attacks and premenstrual opioid hyposensitivity.

AB - To assess the biological correlates of the precipitation of migraine attacks in the perimenstrual period, plasma β-endorphin (β-EP) and cortisol responses to naloxone (8 mg iv) and corticotropin releasing hormone (100 μg iv) were evaluated in both the follicular phase and the premenstrual period in 7 patients suffering from menstrual migraine and in 7 healthy, asymptomatic control volunteers. In the controls, naloxone evoked a significant release of both β-EP (F = 5.86, p <0.002) and cortisol (F = 4.43, p <0.008), independently of the menstrual cycle phase (F = 0.31 and 1.04, for β-EP and cortisol, respectively). Menstrual migraine patients, on the other hand, showed a significant hormone response only in the follicular phase, not in the premenstrual period. Corticotropin releasing hormone significantly increased β-EP and cortisol in both the controls and the menstrual migraine patients, independently of the menstrual cycle phase. In both the naloxone and corticotropin releasing hormone testings, the basal β-EP levels measured in the premenstrual period were lower than those observed in the follicular phase (p <0.02). These data demonstrate a cyclical, premenstrual dysfunction of the hypothalamic control exerted by opioids on the hypothalamus-pituitary-adrenal axis. Impairment of this fundamental adaptive mechanism (involved in stress responses and in pain control) could establish a causal relationship between menstrual-related migraine attacks and premenstrual opioid hyposensitivity.

UR - http://www.scopus.com/inward/record.url?scp=0025321916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025321916&partnerID=8YFLogxK

U2 - 10.1046/j.1468-2982.1990.1001051.x

DO - 10.1046/j.1468-2982.1990.1001051.x

M3 - Article

C2 - 2317851

AN - SCOPUS:0025321916

VL - 10

SP - 51

EP - 56

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 1

ER -